Mahdieh Moghiseh

Dr. Mahdieh Moghiseh


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Journal of Instrumentation
Verified
Journal Article
Open access
PDF file
CBC.J. Bateman
C.J. Bateman
DKD. Knight
D. Knight
BBB. Brandwacht
B. Brandwacht
JMJ. Mc Mahon
J. Mc Mahon
JHJ. Healy
J. Healy
PBP.H. Butler
P.H. Butler

18 December 2018 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
MMMahdieh Moghiseh
Mahdieh Moghiseh
CLChiara Lowe
Chiara Lowe
JLJohn G. Lewis
John G. Lewis
Dhiraj KumarDhiraj Kumar
Dhiraj Kumar
ABAnthony Butler
Anthony Butler
ARAamir Younis Raja
Aamir Younis Raja
The purpose of the present study was to demonstrate anin vitroproof of principle that spectral photon-counting CT can measure gold-labelled specific antibodies targeted to specific cancer cells. A crossover study was performed with Raji lymphoma cancer cells and HER2-positive SKBR3 breast cancer cells using a MARS spectral CT scanner. Raji cells were incubated with monoclonal antibody-labelled gold, rituximab (specific antibody to Raji cells), and trastuzumab (as a control); HER2-positive SKBR3 breast cancer cells were incubated with monoclonal antibody-labelled gold, trastuzumab (specific antibody to HER2-positive cancer cells), and rituximab (as a control). The calibration vials with multiple concentrations of nonfunctionalised gold nanoparticles were used to calibrate spectral CT. Spectral imaging results showed that the Raji cells-rituximab-gold and HER2-positive cells-trastuzumab-gold had a quantifiable amount of gold, 5.97 mg and 0.78 mg, respectively. In contrast, both cell lines incubated with control antibody-labelled gold nanoparticles had less gold attached (1.22 mg and 0.15 mg, respectively). These results demonstrate the proof of principle that spectral molecular CT imaging can identify and quantify specific monoclonal antibody-labelled gold nanoparticles taken up by Raji cells and HER2-positive SKBR3 breast cancer cells. The present study reports the future potential of spectral molecular imaging in detecting tumour heterogeneity so that treatment can be tuned accordingly, leading to more effective personalised medicine.

1 February 2018 in Journal of Instrumentation
Verified
Journal Article
Open access
PDF file
RPR.K. Panta
R.K. Panta
SBS.T. Bell
S.T. Bell
JHJ.L. Healy
J.L. Healy
ARAamir Younis Raja
Aamir Younis Raja
CBC.J. Bateman
C.J. Bateman
NAN.G. Anderson
N.G. Anderson

31 January 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
Dhiraj KumarDhiraj Kumar
Dhiraj Kumar
MMMahdieh Moghiseh
Mahdieh Moghiseh
KCKenny Chitcholtan
Kenny Chitcholtan
Isha MutrejaIsha Mutreja
Isha Mutreja
CLChiara Lowe
Chiara Lowe
ARAamir Younis Raja
Aamir Younis Raja
Emerging multifunctional nanoparticulate formulations take advantage of nano-meter scale size and surface chemistry to work as a therapeutic delivery agent and a diagnostic tool for non-invasive real-time monitoring using imaging technologies. Here, we evaluate the selective uptake of 18 nm and 80 nm sized gold nanoparticles (AuNPs) by SKOV3 (4 times higher) ovarian cancer (OC) cells (compared to OVCAR5) in vitro, quantified by inductively coupled plasma (ICP) and MARS spectral photon-counting CT imaging (MARS SPCCT). Based on in vitro analysis, pristine AuNPs (18 nm) and surface modified AuNPs (18 nm) were chosen as a contrast agent for MARS SPCCT. The chemical analysis by FTIR spectroscopy confirmed the luteinizing hormone-releasing hormone (LHRH) conjugation to the AuNPs surface. For the first time, LHRH conjugated AuNPs were used for in vitro and selective in vivo OC targeting. The ICP-MS analysis confirmed preferential uptake of LHRH modified AuNPs by organs residing in the abdominal cavity with OC nodules (pancreas: 0.46 ng mg−1, mesentery: 0.89 ng mg−1, ovary: 1.43 ng mg−1, and abdominal wall: 2.12 ng mg−1) whereas the MARS SPCCT analysis suggested scattered accumulation of metal around the abdominal cavity. Therefore, the study showed the exciting potential of LHRH conjugated AuNPs to target ovarian cancer and also as a potential contrast agent for novel SPCCT imaging technology.

18 March 2018 in Applied Sciences
Verified
Journal Article
Open access
PDF file
ARAamir Younis Raja
Aamir Younis Raja
MMMahdieh Moghiseh
Mahdieh Moghiseh
CBChristopher J. Bateman
Christopher J. Bateman
NRNiels De Ruiter
Niels De Ruiter
BSBenjamin Schon
Benjamin Schon
NANigel G. Anderson
Nigel G. Anderson
Material decomposition methods are used to identify and quantify multiple tissue components in spectral CT but there is no published method to quantify the misidentification of materials. This paper describes a new method for assessing misidentification and mis-quantification in spectral CT. We scanned a phantom containing gadolinium (1, 2, 4, 8 mg/mL), hydroxyapatite (54.3, 211.7, 808.5 mg/mL), water and vegetable oil using a MARS spectral scanner equipped with a poly-energetic X-ray source operated at 118 kVp and a CdTe Medipix3RX camera. Two imaging protocols were used; both with and without 0.375 mm external brass filter. A proprietary material decomposition method identified voxels as gadolinium, hydroxyapatite, lipid or water. Sensitivity and specificity information was used to evaluate material misidentification. Biological samples were also scanned. There were marked differences in identification and quantification between the two protocols even though spectral and linear correlation of gadolinium and hydroxyapatite in the reconstructed images was high and no qualitative segmentation differences in the material decomposed images were observed. At 8 mg/mL, gadolinium was correctly identified for both protocols, but concentration was underestimated by over half for the unfiltered protocol. At 1 mg/mL, gadolinium was misidentified in 38% of voxels for the filtered protocol and 58% of voxels for the unfiltered protocol. Hydroxyapatite was correctly identified at the two higher concentrations for both protocols, but mis-quantified for the unfiltered protocol. Gadolinium concentration as measured in the biological specimen showed a two-fold difference between protocols. In future, this methodology could be used to compare and optimize scanning protocols, image reconstruction methods, and methods for material differentiation in spectral CT.

28 May 2023
Verified
Book Chapter
Closed access
PDF file
MMMahdieh Moghiseh
Mahdieh Moghiseh
JCJennifer A. Clark
Jennifer A. Clark
MAMaya R. Amma
Maya R. Amma
KCKrishna M. Chapagain
Krishna M. Chapagain
DDDevyani Dixit
Devyani Dixit
MCMARS Collaboration
MARS Collaboration